Inés Romero-Carramiñana

ORCID: 0000-0003-0528-8720
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mitochondrial Function and Pathology
  • ATP Synthase and ATPases Research
  • Heat shock proteins research
  • Adipose Tissue and Metabolism
  • Biosensors and Analytical Detection
  • Adipokines, Inflammation, and Metabolic Diseases
  • Cancer, Hypoxia, and Metabolism
  • Advanced biosensing and bioanalysis techniques
  • Advanced Biosensing Techniques and Applications
  • Pancreatic function and diabetes
  • Adenosine and Purinergic Signaling
  • Exercise and Physiological Responses

Centro de Biología Molecular Severo Ochoa
2021-2024

Universidad Autónoma de Madrid
2021-2024

Consejo Superior de Investigaciones Científicas
2021-2024

Centre for Biomedical Network Research on Rare Diseases
2021-2024

Instituto de Salud Carlos III
2021-2024

Research Institute Hospital 12 de Octubre
2021-2024

Centro de Investigación Biomédica en Red
2023

Institut de Biomedicina de la Universitat de Barcelona
2023

Universitat de Barcelona
2023

Instituto de Investigación de Enfermedades Raras
2022

The mitochondrial ATP synthase emerges as key hub of cellular functions controlling the production ATP, signaling, and fate. It is regulated by ATPase inhibitory factor 1 (IF1), which highly abundant in neurons. Herein, we ablated or overexpressed IF1 mouse neurons to show that dose defines fraction active/inactive enzyme vivo, thereby function reactive oxygen species (mtROS). Transcriptomic, proteomic, metabolomic analyses indicate regulates metabolism, synaptic function, cognition....

10.1371/journal.pbio.3001252 article EN cc-by PLoS Biology 2021-05-13

Abstract ATPase Inhibitory Factor 1 (IF1) regulates the activity of mitochondrial ATP synthase. The expression IF1 in differentiated human and mouse cells is highly variable. In intestinal cells, overexpression protects against colon inflammation. Herein, we have developed a conditional IF1-knockout model epithelium to investigate role function tissue homeostasis. results show that IF1-ablated mice increased synthase/hydrolase activities, leading profound dysfunction pro-inflammatory...

10.1038/s41419-023-05957-z article EN cc-by Cell Death and Disease 2023-07-12

The coexistence of two pools ATP synthase in mitochondria has been largely neglected despite vitro indications for the existence reversible active/inactive state transitions F1-domain enzyme. Herein, using cells and from mouse tissues, we demonstrate vivo synthase: one active, other IF1-bound inactive. IF1 is required oligomerization inactivation proper cristae formation. Immunoelectron microscopy shows co-distribution synthase, placing inactive "sluggish" preferentially at tips....

10.1038/s42003-023-05214-1 article EN cc-by Communications Biology 2023-08-12

Abstract Lung cancer is the leading cause of cancer-related death worldwide despite success therapies targeting oncogenic drivers and immune-checkpoint inhibitors. Although metabolic enzymes offer additional targets for therapy, precise proteome lung adenocarcinomas unknown, hampering its clinical translation. Herein, we used Reverse Phase Protein Arrays to quantify changes in glycolysis, oxidation pyruvate, fatty acid metabolism, oxidative phosphorylation, antioxidant response protein...

10.1038/s41389-022-00400-y article EN cc-by Oncogenesis 2022-05-09

The ability of alternative splicing mechanisms to control gene expression is increasingly being recognized as relevant for adipose tissue function. SF3B1, a key component the SF3B complex directly involved in spliceosome formation, was previously reported be significantly induced brown under cold-induced thermogenic activation. Here, we identify that noradrenergic cAMP-mediated stimulation increases SF3B1 and beige adipocytes. We further show pladienolide-B, drug binds inhibit pre-mRNA by...

10.1016/j.bcp.2023.116014 article EN cc-by-nc-nd Biochemical Pharmacology 2023-12-28

T cells experience metabolic reprogramming to an enhanced glycolysis upon activation. Herein, we have investigated whether ATPase Inhibitory Factor 1 (IF1), the physiological inhibitor of mitochondrial ATP synthase, participates in rewiring a particular phenotype. We show that activation naive CD4

10.1016/j.isci.2024.109863 article EN cc-by iScience 2024-05-03
Coming Soon ...